Skip to content
Medical Health Aged Care

Outbreaks, Australian CDC, misinformation & climate change on agenda at Adelaide health conference

Public Health Association of Australia 2 mins read

Media alert

 

11 June 2025

Outbreaks, Australian CDC, misinformation & climate change on agenda at Adelaide health conference

 

Media are invited to the Communicable Diseases and Immunisation Conference in Kaurna Country/Adelaide where more than 600 delegates are discussing the latest research into infectious diseases, immunisation, misinformation and disinformation, and the forthcoming Australian Centre for Disease Control (CDC).

Two sessions on Wednesday are devoted to the CDC. One features local and global perspectives including the first five years of the Gulf CDC in Saudi Arabia, and the Australian Government’s COVID-19 response. That’s followed at 12:45pm by three senior departmental officials who’ll give international, national, and jurisdictional perspectives on the new Australian entity.

The event is organised by the Public Health Association, the peak body for public health in Australia. We can supply virtual passes for journalists who can’t attend in person.

 

What: Communicable Diseases and Immunisation Conference (CDIC 2025)

When: 9am - 5:45pm Wed 11 June, and 9am – 3pm Thurs 12 June 2025

Where: Adelaide Convention Centre, North Terrace

Who: The confirmed speakers include:

  • Australian Minister for Health Mark Butler (Thurs morn)
  • Deputy Secretary Mary Wood, Head, Interim Australian CDC
  • Dr Sarah Britton, Director of One Health, Interim Australian CDC
  • Prof Catherine Bennett, Deakin University epidemiologist, and former member of the independent panel into the Australian Government’s COVID-19 response inquiry
  • Prof Nicola Spurrier, Chief Public Health Officer, SA Health
  • Prof Pasi Penttinen, CEO, Gulf Center for Disease Prevention & Control (Saudi Arabia)
  • Prof Brett Sutton, Director of Health & Security, CSIRO
  • Dr Dawn Casey, Deputy CEO, National Aboriginal Community Controlled Health Organisation
  • Liam Mannix, national science reporter, The Age

 

Further details and full agenda here.

 

For further information/comment:

Paris Lord (he/him), PHAA Communications & Media Manager, 0478 587 917, [email protected] 

 


Key Facts:

What: Communicable Diseases and Immunisation Conference (CDIC 2025)

When: 9am - 5:45pm Wed 11 June, and 9am – 3pm Thurs 12 June 2025

Where: Adelaide Convention Centre, North Terrace


About us:

About the Public Health Association of Australia

We’re Australia's peak body for public health and advocate for the health and wellbeing of everyone. We strive to help prevent – rather than cure – illness and disease. More at https://www.phaa.net.au/


Contact details:

Paris Lord (he/him), PHAA Communications & Media Manager, 0478 587 917, [email protected] 

Media

More from this category

  • Government Federal, Medical Health Aged Care
  • 25/06/2025
  • 00:05
ACSQHC

Spirometry in decline: a vital test for COPD left behind

25 June 2025 Australians living with chronic obstructive pulmonary disease (COPD) are being exposed to greater health risks as the use of a critical diagnostic test has fallen dramatically, according to a new national report released today by the Australian Commission on Safety and Quality in Health Care. The Atlas Focus Report: COPD found a 31% drop in spirometry testing rates between 2015-16 and 2022-23, despite the test being the gold standard for confirming a diagnosis of COPD. Without spirometry, patients are in danger of misdiagnosis and being prescribed medications that put them at unnecessary risk. COPD is a progressive,…

  • Contains:
  • Medical Health Aged Care
  • 24/06/2025
  • 23:26
Zepp Health

Amazfit Introduces Balance 2 Smartwatch and Helio Strap for Smarter Training, Better Recovery and Peak Performance

Amazfit Smart Wearables Require No Additional Subscription MILPITAS, Calif.–BUSINESS WIRE– Amazfit, a leading global smart wearable brand owned by Zepp Health (NYSE: ZEPP), a…

  • Contains:
  • Medical Health Aged Care
  • 24/06/2025
  • 21:10
Fortrea Holdings Inc

Fortrea & Emery Pharma Announce Strategic Collaboration to Deliver FDA Compliant Drug-Drug-Interaction Studies Using Rifampin

Collaboration enables testing of nitrosamine impurities, allowing sponsors to demonstrate acceptable use of rifampin in drug-drug interaction studiesDURHAM, N.C., June 24, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced a strategic collaboration with Emery Pharma, a leading analytical and bioanalytical CRO providing testing services under current Good Manufacturing Practice (cGMP) and Good Laboratory Practice (GLP), to provide rapid lot-by-lot, 1-methyl-4-nitrosopiperazine (MNP) testing of rifampin, the preferred drug for drug-drug interaction (DDI) studies, to certify impurities are below the Acceptable Intake (AI) Limit set by U.S. Food and Drug Administration (FDA)…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.